Trident Lifeline Limited (BOM:543616)

Market Cap	3.20B -4.4%
Revenue (ttm)	1.27B +111.5%
Net Income	159.28M +57.7%
EPS	13.78 +57.0%
Shares Out	11.93M
PE Ratio	19.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	11,310
Open	268.00
Previous Close	n/a
Day's Range	268.00 - 268.00
52-Week Range	222.00 - 328.00
Beta	-0.26
RSI	46.03
Earnings Date	Feb 19, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target...

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Employees: 74
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543616

Financial Performance

In fiscal year 2025, Trident Lifeline's revenue was 869.65 million, an increase of 94.86% compared to the previous year's 446.29 million. Earnings were 117.48 million, an increase of 85.18%.